Your browser doesn't support javascript.
loading
Motor unit number index and neurophysiological index as candidate biomarkers of presymptomatic motor neuron loss in amyotrophic lateral sclerosis.
Escorcio-Bezerra, Marcio Luiz; Abrahao, Agessandro; Nunes, Karlo Faria; De Oliveira Braga, Nadia Iandoli; Oliveira, Acary Souza Bulle; Zinman, Lorne; Manzano, Gilberto Mastrocola.
Afiliação
  • Escorcio-Bezerra ML; Department of Neurology and Neurosurgery, Escola Paulista de Medicina, Universidade Federal de São Paulo, Rua Pedro de Toledo, 650, 04039-002, São Paulo, SP, Brazil.
  • Abrahao A; Department of Neurology and Neurosurgery, Escola Paulista de Medicina, Universidade Federal de São Paulo, Rua Pedro de Toledo, 650, 04039-002, São Paulo, SP, Brazil.
  • Nunes KF; Sunnybrook Health Sciences Centre, Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • De Oliveira Braga NI; Department of Neurology and Neurosurgery, Escola Paulista de Medicina, Universidade Federal de São Paulo, Rua Pedro de Toledo, 650, 04039-002, São Paulo, SP, Brazil.
  • Oliveira ASB; Department of Neurology and Neurosurgery, Escola Paulista de Medicina, Universidade Federal de São Paulo, Rua Pedro de Toledo, 650, 04039-002, São Paulo, SP, Brazil.
  • Zinman L; Department of Neurology and Neurosurgery, Escola Paulista de Medicina, Universidade Federal de São Paulo, Rua Pedro de Toledo, 650, 04039-002, São Paulo, SP, Brazil.
  • Manzano GM; Sunnybrook Health Sciences Centre, Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Muscle Nerve ; 58(2): 204-212, 2018 Aug.
Article em En | MEDLINE | ID: mdl-29381812
ABSTRACT

INTRODUCTION:

Our objective was to determine the utility of motor unit number index (MUNIX) and neurophysiological index (NI) as surrogate biomarkers of disease progression in limbs without clinical signs of lower motor neuron (LMN) involvement from patients with slowly progressive amyotrophic lateral sclerosis (ALS).

METHODS:

Patients with slowly progressive ALS and at least 1 clinically unaffected limb were prospectively enrolled. Clinical signs of LMN loss and results from hand-held dynamometer (HHD), revised ALS Functional Rating Scale (ALSFRS-R), mean-MUNIX (from 3 different muscles), and NI were longitudinally recorded.

RESULTS:

Eighteen patients with 43 presymptomatic muscles were evaluated. Twenty-seven muscles remained clinically unaffected during study, with stable ALSFRS-R subscores and HHD measures. However, a significant decline in mean-MUNIX and NI was detected.

DISCUSSION:

Mean-MUNIX and NI were more sensitive than clinical measures at detecting LMN loss in presymptomatic limbs from patients with slowly progressive ALS. Therefore, these electrophysiological biomarkers should be included in early study phases as meaningful outcome measures. Muscle Nerve 58 204-212, 2018.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibras Musculares Esqueléticas / Esclerose Lateral Amiotrófica / Neurônios Motores Tipo de estudo: Observational_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibras Musculares Esqueléticas / Esclerose Lateral Amiotrófica / Neurônios Motores Tipo de estudo: Observational_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article